History
The Department of Medical Retina and Neuro-ophthalmology was founded in 1998.
Faculty experts and team
The department has 7 doctors (Four PhD and three masters of medicine), including 2 senior consultants, 1 consultant, 3 associate consultants and 1 doctor in training. In order to improve the clinical knowledge preservation and scientific research ability of young doctors, our department has been sponsored in a series of national follow-up education projects for neuro-ophthalmology and fundus imaging for many years, a variety of fundus reading meetings, OCT training courses, and regular communication. We also hold several learning activities with departments such as cataract, glaucoma and corneal diseases.
Clinical work and scientific research
After 30 years of development, our department has developed from a single laser treatment of diabetic retinopathy to a clinical department that can treat a variety of complex vitreoretinal diseases, optic nerve diseases, gene diagnosis of fundus diseases and screening of neonatal ophthalmopathy. In addition to being widely used in the treatment of diabetic fundus diseases, laser fundus therapy is also applied to retinal vascular diseases, macular lesions, formation of subretinal neovascularization, peripheral retinal hiatus and retinal choroidal tumors. On the basis of traditional laser photocoagulation, transpupillary thermotherapy (TTT) was developed, and photodynamic therapy (PDT) was first developed in Tianjin to treat age-related macular degeneration. Photodynamic therapy (PDT) combined with intravitreal injection for age-related macular degeneration and intravitreal injection combined with fundus laser for treatment of neovascular diseases have achieved satisfactory results. Recently, the newly developed micropulse laser fundus treatment of diabetic macular edema has also achieved satisfactory results which need to be widely promoted.
Now, our department has laser fundus equipment (single point 577, multi-point 577, micro-pulse) and various advanced inspection equipment, such as: Omburg 200Tx ultra-wide angle fundus photography, Omburg 200Tx ultra-wide angle fundus fluorescence angiography, optical coherence tomography (RTVue XR Avanti, Optovue), ssOCT (triton), OCT blood flow imaging, multi-spectrum, i maging (RHA), RetCam, Heidelberg combined imaging equipment, and Espion electrophysiology, among others . By the end of 2018, our department will have carried out more than 10 phase III clinical trials and 3 phase IV observation projects, most of which are international multi-center studies mainly focusing on anti-VEGF drug treatment-related fundus diseases such as age-related macular degeneration, pathological myopia complicated with CNV, diabetic retinopathy, retinal vein occlusion or macular edema. More than 200 subjects participated in the clinical trials and achieved good clinical results. It has been inspected by foreign security departments and checked by the evaluation center of the State Drug Administration many times, and the quality of clinical trials has been widely recognized. The department has published more than 50 articles in SCI and Chinese core journals, including 6 articles in SCI. |
